ArticleAnnals of medicine and surgery (2012)2026

Zidesamtinib in ROS1-positive NSCLC with brain metastases: clinical evidence and therapeutic implications.

Abdihakim Sheikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.